Sevoflurane protects against renal ischemia and reperfusion injury in mice via the transforming growth factor-β1 pathway
Authors:
- 1 July 2008
- journal article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 295 (1) , F128-F136
Abstract
We previously demonstrated that several clinically utilized volatile anesthetics including sevoflurane protected against renal ischemia-reperfusion (IR) injury by reducing necrosis and inflammation in vivo. We also demonstrated that volatile anesthetics produced direct anti-necrotic and anti-inflammatory effects in cultured renal tubules via mechanisms involving the externalization of phosphatidylserine and subsequent release of transforming growth factor (TGF)-β1. In this study, we tested the hypothesis that volatile anesthetic-mediated renal protection requires TGF-β1 and SMAD3 signaling in vivo. We subjected TGF-β1+/+, TGF-β1+/−, SMAD3+/+, or SMAD3−/− mice to renal IR under anesthesia with pentobarbital sodium or with sevoflurane. Although TGF-β1+/+ and SMAD3+/+ mice were significantly protected against renal IR injury under sevoflurane anesthesia with reduced necrosis and inflammation, TGF-β1+/− mice and SMAD3−/− mice were not protected against renal IR with sevoflurane. Furthermore, a neutralizing TGF-β1 antibody blocked renal protection with sevoflurane in TGF-β1+/+ mice. Sevoflurane caused nuclear translocation of SMAD3 and reduced the TNF-α-induced nuclear translocation of NF-κB in primary cultures of proximal tubules from TGF-β1+/+ but not in TGF-β1+/− mice. Finally, sevoflurane protected against necrosis induced with hydrogen peroxide in primary cultures of proximal tubules from TGF-β1+/+ mice or SMAD3+/+ mice but not in proximal tubules from TGF-β1+/− or SMAD3−/− mice. Therefore, we demonstrate in this study that sevoflurane-mediated renal protection in vivo requires the TGF-β1→SMAD3 signaling pathway.Keywords
This publication has 33 references indexed in Scilit:
- Sevoflurane-mediated TGF-β1 signaling in renal proximal tubule cellsAmerican Journal of Physiology-Renal Physiology, 2008
- Macrophage TNF-α contributes to insulin resistance and hepatic steatosis in diet-induced obesityAmerican Journal of Physiology-Endocrinology and Metabolism, 2007
- Anti-inflammatory and antinecrotic effects of the volatile anesthetic sevoflurane in kidney proximal tubule cellsAmerican Journal of Physiology-Renal Physiology, 2006
- Receptor regulated SMADS in TGF beta signalingFrontiers in Bioscience-Landmark, 2003
- A receptor for phosphatidylserine-specific clearance of apoptotic cellsNature, 2000
- The Inhibitory Effects of Transforming Growth Factor-Beta-1 (TGF-β1) in Autoimmune DiseasesJournal of Autoimmunity, 2000
- TGF-β signaling from receptors to the nucleusMicrobes and Infection, 1999
- Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.Journal of Clinical Investigation, 1998
- Treatment of acute renal failureKidney International, 1998
- Transforming growth factor‐β1 in reproductionMolecular Reproduction and Development, 1994